Polymorphism Arg389 of β1 adrenergic receptor is associated with orthostatic hypotension in hypertensive patients

被引：0
|
作者：
Fan, X. H. [1 ,2 ]
Wang, Y. [4 ]
Zhen, Y. [4 ]
Sun, K. [4 ]
Wang, H. [1 ,2 ,4 ]
Wang, X. [4 ]
Chen, J. [4 ]
Li, W. [1 ,2 ]
Han, Y. [1 ,2 ]
Song, W. [1 ,2 ]
Zou, Y. [1 ,2 ]
Wu, H. [1 ,2 ]
Zhou, X. [1 ,2 ]
Wang, H. [1 ,2 ,4 ]
Hui, R. [3 ,4 ]
机构：
[1] Chinese Acad Med Sci, Div Hypertens, Dept Cardiol, Cardiovasc Inst, Beijing 100037, Peoples R China
[2] Chinese Acad Med Sci, Div Hypertens, Dept Cardiol, FuWai Hosp, Beijing 100037, Peoples R China
[3] Peking Union Med Coll, Key Lab Clin Cardiovascular Genet, Minist Educ, Div Hypertens,Dept Cardiol, Beijing 100021, Peoples R China
[4] Sino German Lab Mol Med, Beijing, Peoples R China
来源：
JOURNAL OF HYPERTENSION | 2008年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S136 / S136
页数：1
相关论文
共 50 条
  • [1] Orthostatic blood pressure change is associated with peripheral artery disease and β1-adrenergic receptor Gly389 polymorphism in untreated hypertensive patients
    Fan, Xiao H.
    Yang, Xiaomin
    Sun, Kai
    Wang, Yibo
    Wang, Hu
    Zhen, Yisong
    Wang, Xiaojian
    Li, Weiju
    Han, Yunfeng
    Fu, Chunyan
    Chen, Jingzhou
    Song, Xiaodong
    Song, Weihua
    Wu, Haiying
    Yang, Yue J.
    Zhou, Xianliang
    Hui, Rutai
    HYPERTENSION, 2008, 52 (04) : E96 - E96
  • [2] Real-time optical recording of β1-adrenergic receptor activation reveals supersensitivity of the Arg389 variant to carvedilol
    Rochais, Francesca
    Vilardaga, Jean-Pierre
    Nikolaev, Viacheslav O.
    Buenemann, Moritz
    Lohse, Martin J.
    Engelhardt, Stefan
    JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (01): : 229 - 235
  • [3] β1-adrenergic receptor(Arg389Gly) polymorphism and response to bisoprolol in patients with chronic heart failure
    俞文萍
    China Medical Abstracts (Internal Medicine), 2006, (04) : 193 - 194
  • [4] Arg389Gly polymorphism of the human β1-adrenergic receptor in patients with nonfatal acute myocardial infarction
    Iwai, C
    Akita, H
    Kanazawa, K
    Shiga, N
    Terashima, M
    Matsuda, Y
    Takai, E
    Miyamoto, Y
    Shimizu, M
    Kajiya, T
    Hayashi, T
    Yokoyama, M
    AMERICAN HEART JOURNAL, 2003, 146 (01) : 106 - 109
  • [5] The Arg 389 Gly β1-adrenergic receptor gene polymorphism and human fat cell lipolysis
    M Rydén
    J Hoffstedt
    P Eriksson
    S Bringman
    P Arner
    International Journal of Obesity, 2001, 25 : 1599 - 1603
  • [6] The Arg 389 Gly β1-adrenergic receptor gene polymorphism and human fat cell lipolysis
    Rydén, M
    Hoffstedt, J
    Eriksson, P
    Bringman, S
    Arner, P
    INTERNATIONAL JOURNAL OF OBESITY, 2001, 25 (11) : 1599 - 1603
  • [7] The Gly389Arg β1-adrenergic receptor polymorphism:: A predictor of response to β-blocker treatment?
    Brodde, OE
    Stein, CM
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2003, 74 (04) : 299 - 302
  • [8] The Gly389Arg polymorphism determines the activation kinetics of the human β1-adrenergic receptor
    Ahles, A.
    Rochais, F.
    Rodewald, F.
    Buenemann, M.
    Engelhardt, S.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2012, 385 : 4 - 4
  • [9] β1-Adrenergic receptor Arg389Gly polymorphism affects the antiarrhythmic efficacy of flecainide in patients with coadministration of β-blockers
    Doki, Kosuke
    Sekiguchi, Yukio
    Kuga, Keisuke
    Aonuma, Kazutaka
    Homma, Masato
    PHARMACOGENETICS AND GENOMICS, 2016, 26 (10): : 481 - 485
  • [10] Ex ante economic evaluation of genetic testing for the ARG389 beta1-adrenergic receptor polymorphism to support bucindolol treatment decisions in Stage III/IV heart failure
    Alkhatib, Nimer S.
    Ramos, Kenneth
    Slack, Marion
    Erstad, Brian
    Gharaibeh, Mahdi
    Klimecki, Walter
    Karnes, Jason H.
    Sweitzer, Nancy K.
    Abraham, Ivo
    EXPERT REVIEW OF PRECISION MEDICINE AND DRUG DEVELOPMENT, 2018, 3 (05): : 319 - 329
12345